Pacific Health Foundation Report issue

Foundation Phase 3 Phase 4

Organization Overview

First Clinical Trial
2004
NCT00575224
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

interferon alpha-2b (Intron-A) (1 trial)

ribavirin (virazole) (1 trial)

Drugs in Phase 3 Trials (1)

argireline (1 trial)

Drugs in Other Trials (1)

entecavir (baraclude) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4